SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma

The large screening of exons 18 to 21 of the epidermal growth factor receptor (EGFR) gene may lead to the discovery of rare, atypical molecular alterations for which the sensitivity to tyrosine kinase inhibitors (TKIs) remains uncertain. We are reporting a rare exon 18 EGFR mutation (p.E709_710 >...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: D'Haene, Nicky, Le Mercier, Marie, Salmon, Isabelle, Mekinda, Zita, Remmelink, Myriam, Berghmans, Thierry
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2018
Aiheet:
Precision Medicine Clinic: Molecular Tumor Board
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324642/
https://ncbi.nlm.nih.gov/pubmed/30413663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0016
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia